Galderma closes the sale of Bübchen to Dallmann’s Pharma: the advisors

Switzerland-based company engaged in providing medical skin treatments, Galderma, a portfolio company of EQT, has sold its baby skincare business Bubchen to Dallmann Pharma, a wholly-owned subsidiary of Germany-based confectionery group Katjes. The transaction is in line with Dallmann’s growth strategy and will help to generate synergies as both the companies have a similar customer base.

White & Case acted as legal advisor to Galderma in this transaction.
Orth Kluth Rechtsanwalte acted as legal advisor to Dallmann Pharma.

FabioAdmin

SHARE